The risk of second primary malignancy is increased in differentiated thyroid cancer patients with a cumulative131I dose over 37 GBq-Reference-Cited by-同舟云学术

The risk of second primary malignancy is increased in differentiated thyroid cancer patients with a cumulative131I dose over 37 GBq

Published:2014-10-10 Issue:1 Volume:83 Page:117-123
ISSN:0300-0664
Container-title:Clinical Endocrinology
language:en
Short-container-title:Clin Endocrinol

Author:

Khang Ah Reum¹,Cho Sun Wook¹²,Choi Hoon Sung¹,Ahn Hwa Young¹³,Yoo Won Sang¹⁴,Kim Kyung Won¹,Kang Keon Wook⁵,Yi Ka Hee⁶,Park Do Joon¹,Lee Dong Soon⁷,Chung June-Key⁵,Cho Bo Youn¹³,Park Young Joo¹

Affiliation:

1. Department of Internal Medicine; Seoul National University College of Medicine; Seoul Korea

2. Department of Internal Medicine; National Medical Center; Seoul Korea

3. Department of Internal Medicine; Chung-Ang University Hospital; Seoul Korea

4. Department of Internal Medicine; Dankook University Hospital; Cheonan-si Korea

5. Department of Nuclear Medicine; Seoul National University College of Medicine; Seoul Korea

6. Department of Internal Medicine; Seoul National University Boramae Medical Center; Seoul Korea

7. Department of Laboratory Medicine; Seoul National University College of Medicine; Seoul Korea

Funder

the Korean Foundation for Cancer Research

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism,Endocrinology

Reference22 articles.

1. Primary malignancies of the thyroid: epidemiologic analysis of the Florida Cancer Data System registry;Mulla;Annals of Epidemiology,2000

2. Thyroid cancer: is the incidence still increasing?;Hodgson;Annals of Surgical Oncology,2004

3. Descriptive epidemiology of thyroid cancer in Los Angeles County, 1972-1995;Haselkorn;Cancer Causes and Control,2000

4. Changes in the clinicopathological characteristics and outcomes of thyroid cancer in Korea over the past four decades;Cho;Thyroid,2013

5. Long-term trends in thyroid carcinoma: a population-based study in Olmsted County, Minnesota, 1935-1999;Burke;Mayo Clinic Proceedings,2005

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in the selection and timing of postoperative radioiodine treatment in patients with differentiated thyroid carcinoma;Annals of Nuclear Medicine;2024-07-24

2. Stereotactic body radiation therapy for multiple lung cancers in a patient with six primary cancers: a case report;Journal of Medical Case Reports;2024-07-11

3. Radioactive Iodine Therapy in Differentiated Thyroid Cancer: An Update on Dose Recommendations and Risk of Secondary Primary Malignancies;Seminars in Nuclear Medicine;2024-07

4. Exploring the Susceptibility to Multiple Primary Tumors in Patients with Differentiated Thyroid Cancer;Diagnostics;2024-06-07

5. Korean Thyroid Association Guidelines on the Management of Differentiated Thyroid Cancers; Part III. Management of Advanced Differentiated Thyroid Cancers - Chapter 3. Radioactive Iodine Therapy in Advanced Thyroid Cancer 2024;International Journal of Thyroidology;2024-05-30